BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11367447)

  • 1. Antiviral drug reduces shedding of herpes virus.
    Newsline People AIDS Coalit N Y; 1998 Feb; ():36. PubMed ID: 11367447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons. A double-blind, placebo-controlled trial.
    Schacker T; Hu HL; Koelle DM; Zeh J; Saltzman R; Boon R; Shaughnessy M; Barnum G; Corey L
    Ann Intern Med; 1998 Jan; 128(1):21-8. PubMed ID: 9424977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Famciclovir reduces viral mucosal shedding in HSV-seropositive persons.
    Leone P; Warren T; Hamed K; Fife K; Wald A
    Sex Transm Dis; 2007 Nov; 34(11):900-7. PubMed ID: 17538513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Famciclovir suppression of asymptomatic and symptomatic recurrent anogenital herpes simplex virus shedding in women: a randomized, double-blind, double-dummy, placebo-controlled, parallel-group, single-center trial.
    Sacks SL
    J Infect Dis; 2004 Apr; 189(8):1341-7. PubMed ID: 15073669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug effective against herpes.
    AIDS Alert; 1996 Apr; 11(4):48. PubMed ID: 11363406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals. Collaborative Famciclovir HIV Study Group.
    Romanowski B; Aoki FY; Martel AY; Lavender EA; Parsons JE; Saltzman RL
    AIDS; 2000 Jun; 14(9):1211-7. PubMed ID: 10894286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
    Highleyman L
    BETA; 1998 Oct; ():5. PubMed ID: 11365993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of herpes simplex and varicella-zoster virus infections.
    Erlich KS
    West J Med; 1997 Mar; 166(3):211-5. PubMed ID: 9143202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valuable clinical tips from recent medical meetings.
    Prescott LM
    Body Posit; 1999 Feb; 12(2):13-4. PubMed ID: 11366166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Famciclovir safe and effective for herpes.
    AIDS Patient Care STDS; 1997 Oct; 11(5):375. PubMed ID: 11361826
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
    Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
    JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-day versus 5-day famciclovir as treatment of recurrences of genital herpes: results of the FaST study.
    Bodsworth N; Bloch M; McNulty A; Denham I; Doong N; Trottier S; Adena M; Bonney MA; Agnew J;
    Sex Health; 2008 Sep; 5(3):219-25. PubMed ID: 18771636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Famciclovir safe and effective for management of shingles.
    AIDS Patient Care STDS; 1997 Jun; 11(3):198. PubMed ID: 11361804
    [No Abstract]   [Full Text] [Related]  

  • 14. Famvir effective in suppressing recurrent genital herpes.
    AIDS Patient Care STDS; 1998 Dec; 12(12):944. PubMed ID: 11362073
    [No Abstract]   [Full Text] [Related]  

  • 15. [The efficiency of combined therapy of herpes virus infection in HIV infected patients].
    Papuashvili MN; Shchelkanov MIu
    Vopr Virusol; 2004; 49(2):25-9. PubMed ID: 15106380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antivirals for herpes simplex viruses.
    Sawleshwarkar S; Dwyer DE
    BMJ; 2015 Jul; 351():h3350. PubMed ID: 26160487
    [No Abstract]   [Full Text] [Related]  

  • 17. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
    LeBlanc RA; Pesnicak L; Godleski M; Straus SE
    J Infect Dis; 1999 Sep; 180(3):594-9. PubMed ID: 10438344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of daily valacyclovir suppression on herpes simplex virus type 2 viral shedding in HSV-2 seropositive subjects without a history of genital herpes.
    Sperling RS; Fife KH; Warren TJ; Dix LP; Brennan CA
    Sex Transm Dis; 2008 Mar; 35(3):286-90. PubMed ID: 18157071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Herpes simplex].
    Välimaa H; Seppänen M; Hukkanen V
    Duodecim; 2013; 129(1):31-40. PubMed ID: 23431880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus type 2 (HSV-2) genital shedding in HSV-2-/HIV-1-co-infected women receiving effective combination antiretroviral therapy.
    Péré H; Rascanu A; LeGoff J; Matta M; Bois F; Lortholary O; Leroy V; Launay O; Bélec L;
    Int J STD AIDS; 2016 Mar; 27(3):178-85. PubMed ID: 25769886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.